Is Ozempic or Mounjaro covered in Nova Scotia?
By GLP1Prices Editorial · Plan rules checked November 14, 2026 · Sources under each section
Is Ozempic, Wegovy, Mounjaro or Zepbound covered by Nova Scotia Pharmacare?
Nova Scotia Pharmacare is a set of provincial programs, among them Seniors' Pharmacare, for seniors without other drug coverage, and Family Pharmacare, for families with no drug coverage or high drug costs. They pay for the drugs the Nova Scotia Formulary lists as their benefits, and for exception status drugs after a request is approved. Their answer for each drug:
Sources: Nova Scotia Formulary, November 2026 (read November 14, 2026); Nova Scotia: Apply for the Seniors' Pharmacare Program (read November 14, 2026); Nova Scotia: Register for the Family Pharmacare Program (read November 14, 2026)
Ozempic: Only if Pharmacare approves your prescriber's written exception status request under the criteria published in Appendix III of the Formulary.
Sources: Nova Scotia Formulary, November 2026 (read November 14, 2026); Nova Scotia: Criteria for Coverage of Exception Status Drugs (Appendix III), November 2026 (read November 14, 2026)
Generic semaglutide (Apo-Semaglutide, Dr. Reddy's): Only if the same exception status request is approved: the generic pens share the status and the criteria of the Ozempic pens.
Sources: Nova Scotia Formulary, November 2026 (read November 14, 2026); Nova Scotia: Criteria for Coverage of Exception Status Drugs (Appendix III), November 2026 (read November 14, 2026)
Mounjaro: No. The Nova Scotia Formulary has no Mounjaro or tirzepatide product.
Source: Nova Scotia Formulary, November 2026 (read November 14, 2026)
Wegovy: No. The Formulary's semaglutide products are the Ozempic pens, the generic pens and Rybelsus; Wegovy is not one of them.
Source: Nova Scotia Formulary, November 2026 (read November 14, 2026)
Zepbound: No. The Nova Scotia Formulary has no Zepbound or tirzepatide product.
Source: Nova Scotia Formulary, November 2026 (read November 14, 2026)
Rybelsus: Only if an exception status request is approved under the criteria Appendix III publishes for semaglutide tablets.
Sources: Nova Scotia Formulary, November 2026 (read November 14, 2026); Nova Scotia: Criteria for Coverage of Exception Status Drugs (Appendix III), November 2026 (read November 14, 2026)
The short answer
On the Nova Scotia Formulary, Ozempic, generic semaglutide and Rybelsus have exception status: Pharmacare pays only after it reviews your prescriber's written request and the criteria published in Appendix III are met. Mounjaro, Zepbound and Wegovy are not on the Formulary. Without coverage you pay the pharmacy's price: the lowest prices we list in Nova Scotia are below.
Sources: Nova Scotia Formulary, November 2026 (read November 14, 2026); Nova Scotia: Criteria for Coverage of Exception Status Drugs (Appendix III), November 2026 (read November 14, 2026)
What you pay without coverage in Nova Scotia
Mounjaro, Zepbound and Wegovy are not on the Nova Scotia Formulary, and an exception status drug is paid only once its request is approved. Without coverage, the pharmacy's price applies. These are the lowest prices we list in Nova Scotia, with the pharmacy and the date the price was last updated.
Sources: Nova Scotia Formulary, November 2026 (read November 14, 2026); Nova Scotia: Criteria for Coverage of Exception Status Drugs (Appendix III), November 2026 (read November 14, 2026)
| Drug | Public plan status | Lowest price we list in Nova Scotia |
|---|---|---|
| Ozempic | Exception status (Appendix III) | $265.64 at Shoppers Drug Mart1mg/0.5mL pen, 1 pen · Updated November 20261 pharmacy listed |
| Generic semaglutide (Apo-Semaglutide) | Exception status (Appendix III) | No price listed yet |
| Mounjaro | Not on the Nova Scotia Formulary | No price listed yet |
| Wegovy | Not on the Nova Scotia Formulary | No price listed yet |
| Zepbound | Not on the Nova Scotia Formulary | No price listed yet |
| Rybelsus | Exception status (Appendix III) | No price listed yet |
Status from the plan's own lists (sources under each section below). Prices are the lowest active price we list per drug in Nova Scotia, before any plan or savings card; a pharmacy may add a dispensing fee.
How Nova Scotia Pharmacare decides what it pays
The Nova Scotia Formulary lists the drugs that are benefits under the Pharmacare programs, with a benefit status for each product: a letter for each program that covers it, or E, "Exception Status Drug - see Appendix III". The programs include Seniors' Pharmacare, Family Pharmacare, the Community Services Pharmacare programs and Under 65 Long Term Care Pharmacare.
Source: Nova Scotia Formulary, November 2026 (read November 14, 2026)
Seniors' Pharmacare is for Nova Scotia residents 65 or older with a valid Health Card who don't have prescription drug coverage under another program or plan: you pay an annual premium based on your household income and an annual copayment, both with annual maximums. Family Pharmacare is for families with no drug coverage, or whose drug costs become a financial burden: there is no premium, you pay the full cost until you reach your deductible, and the annual copayment and deductible maximums depend on family size and income.
Sources: Nova Scotia: Apply for the Seniors' Pharmacare Program (read November 14, 2026); Nova Scotia: Register for the Family Pharmacare Program (read November 14, 2026)
An exception status drug is covered only when a person meets the criteria developed by the Atlantic or Canadian Expert Advisory Committees. Your healthcare provider sends a request on the Standard Exception Status Drug Request Form or a specialized form, or online through Ocean, and coverage is approved under the criteria "upon review of a prescriber's written request". Some exception status drugs have criteria codes that allow online payment at the pharmacy.
Sources: Nova Scotia: Pharmacare programs, exception status drugs (read November 14, 2026); Nova Scotia: Criteria for Coverage of Exception Status Drugs (Appendix III), November 2026 (read November 14, 2026)
For interchangeable products, Pharmacare reimburses up to a maximum reimbursable price (MRP). If you ask for a higher-priced product, the pharmacy can charge you the difference, and that extra cost "is not counted toward their annual maximum copayment or annual maximum deductible".
Source: Nova Scotia Formulary, November 2026 (read November 14, 2026)
Ozempic and generic semaglutide in Nova Scotia
Status: Exception status (Appendix III)
The Nova Scotia Formulary of November 2026 lists the Ozempic 2mg/1.5mL, 2mg/3mL and 4mg/3mL pens (DINs 02471477, 02540258 and 02471469) and the Apotex and Dr. Reddy's generic pens (DINs 02568020, 02568012, 02567806 and 02567814) with benefit status E, exception status, billed per pen. Brand and generic pens are interchangeable and carry one maximum reimbursement price.
Source: Nova Scotia Formulary, November 2026 (read November 14, 2026)
Appendix III publishes the criteria and the claim note for the Ozempic pens "and generic brands". Pharmacare covers them once your prescriber's written request is reviewed and approved under those criteria. If you ask for a higher-priced pen, the pharmacy can charge you the difference above the maximum reimbursement price.
Sources: Nova Scotia: Criteria for Coverage of Exception Status Drugs (Appendix III), November 2026 (read November 14, 2026); Nova Scotia Formulary, November 2026 (read November 14, 2026)
Mounjaro in Nova Scotia
Status: Not on the Nova Scotia Formulary
The Nova Scotia Formulary of November 2026 has no Mounjaro or tirzepatide product, and Appendix III has no tirzepatide criteria. The Formulary lists the drugs the Pharmacare programs pay for, so you pay the pharmacy price for Mounjaro unless another plan covers it.
Sources: Nova Scotia Formulary, November 2026 (read November 14, 2026); Nova Scotia: Criteria for Coverage of Exception Status Drugs (Appendix III), November 2026 (read November 14, 2026)
Wegovy in Nova Scotia
Status: Not on the Nova Scotia Formulary
Under semaglutide, the Formulary of November 2026 lists the Ozempic pens, the generic pens and the Rybelsus tablets. Wegovy is not listed, and Appendix III has no Wegovy criteria.
Sources: Nova Scotia Formulary, November 2026 (read November 14, 2026); Nova Scotia: Criteria for Coverage of Exception Status Drugs (Appendix III), November 2026 (read November 14, 2026)
Zepbound in Nova Scotia
Status: Not on the Nova Scotia Formulary
Zepbound is tirzepatide too, and the Formulary of November 2026 has no tirzepatide product.
Source: Nova Scotia Formulary, November 2026 (read November 14, 2026)
Rybelsus in Nova Scotia
Status: Exception status (Appendix III)
The Rybelsus tablets are on the Formulary with benefit status E, and Appendix III publishes separate criteria and a claim note for semaglutide tablets. The same written-request process applies.
Sources: Nova Scotia Formulary, November 2026 (read November 14, 2026); Nova Scotia: Criteria for Coverage of Exception Status Drugs (Appendix III), November 2026 (read November 14, 2026)
Private and workplace plans
Seniors' Pharmacare is for people who don't have prescription drug coverage under another plan, and Family Pharmacare for families with no drug coverage or whose drug costs become a financial burden. An employer or other private plan sets its own rules: Sun Life and Canada Life put Ozempic on prior authorization, and pay only once they approve the request. Wegovy is covered only on plans that include it. Ask your insurer about Mounjaro and Zepbound, or check with the Coverage Checker.
Sources: Nova Scotia: Apply for the Seniors' Pharmacare Program (read November 14, 2026); Nova Scotia: Register for the Family Pharmacare Program (read November 14, 2026); Sun Life: Prior Authorization Form, OZEMPIC (semaglutide) or generic products, 4233-PA-OZE-E-09-26 (read November 14, 2026); Sun Life: report for plan sponsors on drug management strategies (November 2025) (read November 14, 2026); Canada Life: Workplace benefits, prior-authorization forms (read November 14, 2026); Canada Life: Drug Prior Authorization Form, semaglutide (Ozempic and generics), M6453(Ozempic)-10/26 (read November 14, 2026); Canada Life: Drug Prior Authorization Form, Wegovy (semaglutide), M6453(Wegovy)-8/26 (read November 14, 2026)
Getting a prescription online in Nova Scotia
Each of these drugs needs a prescription: Health Canada's Drug Product Database puts Ozempic, Wegovy, Mounjaro, Zepbound and Apo-Semaglutide in its Prescription schedule. If you don't have a prescriber, our guides list the online providers we track, the provinces each one serves and what they charge.
Sources: Health Canada Drug Product Database: Ozempic, DIN 02471469 (semaglutide; Schedule: Prescription, Schedule D) (read November 11, 2026); Health Canada Drug Product Database: Wegovy, DIN 02528525 (semaglutide; Schedule: Prescription, Schedule D) (read November 11, 2026); Health Canada Drug Product Database: Mounjaro KwikPen, DIN 02551950 (tirzepatide; Schedule: Prescription) (read November 11, 2026); Health Canada Drug Product Database: Zepbound, DIN 02557509 (tirzepatide; Schedule: Prescription) (read November 11, 2026); Health Canada Drug Product Database: Apo-Semaglutide Injection, DIN 02568012 (semaglutide; Schedule: Prescription) (read November 11, 2026)
Where are you in your GLP-1 journey?
Answer a few quick questions — get your cheapest path to a GLP-1 prescription, free.
Frequently asked questions
Does Nova Scotia Pharmacare cover Ozempic?
With exception status. When we read the Nova Scotia Formulary of November 2026, the Ozempic pens (DINs 02471477, 02540258 and 02471469) had benefit status E. Pharmacare covers them once it reviews your prescriber's written request and the criteria in Appendix III are met.
Sources: Nova Scotia Formulary, November 2026 (read November 14, 2026); Nova Scotia: Criteria for Coverage of Exception Status Drugs (Appendix III), November 2026 (read November 14, 2026)
Is generic Ozempic covered in Nova Scotia?
On the same terms as Ozempic. The Apotex and Dr. Reddy's pens (DINs 02568020, 02568012, 02567806 and 02567814) have the same exception status and the same Appendix III criteria, and brand and generic pens carry one maximum reimbursement price.
Sources: Nova Scotia Formulary, November 2026 (read November 14, 2026); Nova Scotia: Criteria for Coverage of Exception Status Drugs (Appendix III), November 2026 (read November 14, 2026)
Is Mounjaro covered in Nova Scotia?
Not by Nova Scotia Pharmacare: the Formulary of November 2026 has no Mounjaro or tirzepatide product. You pay the pharmacy price unless a private plan covers it.
Source: Nova Scotia Formulary, November 2026 (read November 14, 2026)
How much is Ozempic in Nova Scotia without insurance?
The lowest Ozempic price we list in Nova Scotia is $265.64 at Shoppers Drug Mart (1mg/0.5mL pen, 1 pen, updated November 2026). A pharmacy may add a dispensing fee. Every pharmacy's price is on Ozempic prices in Nova Scotia.
Is Wegovy or Zepbound covered in Nova Scotia?
Not by Nova Scotia Pharmacare: neither is on the Formulary of November 2026. A private plan may cover Wegovy if your plan includes it.
Sources: Nova Scotia Formulary, November 2026 (read November 14, 2026); Sun Life: optional drug category, prior authorization from October 15, 2024 (August 13, 2024) (read October 2, 2026); Canada Life: Wegovy prior authorization form M6453 ("not covered under all benefit plans") (read October 2, 2026)
How does my prescriber ask for exception status in Nova Scotia?
With the Standard Exception Status Drug Request Form or a specialized form, or online through Ocean. Pharmacare approves coverage under the published criteria after it reviews the prescriber's written request.
Sources: Nova Scotia: Pharmacare programs, exception status drugs (read November 14, 2026); Nova Scotia: Criteria for Coverage of Exception Status Drugs (Appendix III), November 2026 (read November 14, 2026)
Do Nova Scotia seniors pay for Ozempic?
Seniors' Pharmacare members pay an annual premium based on household income and an annual copayment, both with annual maximums. Ozempic still has exception status: Pharmacare pays only once the exception status request is approved.
Sources: Nova Scotia: Apply for the Seniors' Pharmacare Program (read November 14, 2026); Nova Scotia Formulary, November 2026 (read November 14, 2026); Nova Scotia: Criteria for Coverage of Exception Status Drugs (Appendix III), November 2026 (read November 14, 2026)
Sources
- Nova Scotia Formulary, November 2026 (read November 14, 2026): Page ii: the maximum reimbursable price (MRP) of interchangeable products; if you ask for a higher-priced product, the extra cost "is not counted toward their annual maximum copayment or annual maximum deductible". Page iii: the programs, and the benefit status E, "Exception Status Drug - see Appendix III". Page 23: the Ozempic 2mg/1.5mL, 2mg/3mL and 4mg/3mL pens (DINs 02471477, 02540258 and 02471469) and the Apotex and Dr. Reddy's pens (02568020, 02568012, 02567806 and 02567814), status E, interchangeable, billed per pen, at one maximum reimbursement price; the Rybelsus tablets, status E. No Wegovy, Mounjaro, Zepbound or Saxenda product. The Excel version of the November 2026 Formulary shows the same.
- Nova Scotia: Apply for the Seniors' Pharmacare Program (read November 14, 2026): For Nova Scotia residents 65 or older with a valid Health Card who don't have prescription drug coverage under other programs or plans; an annual premium based on household income and an annual copayment, both with annual maximums; the Formulary lists the benefits.
- Nova Scotia: Register for the Family Pharmacare Program (read November 14, 2026): For families with no drug coverage, or whose drug costs become a financial burden; no premium or fee to join; you pay the full cost until you reach your deductible; annual family copayment and deductible maximums set by family size and income; the Nova Scotia Formulary lists the benefits.
- Nova Scotia: Criteria for Coverage of Exception Status Drugs (Appendix III), November 2026 (read November 14, 2026): Page 1: exception status drugs are approved under the criteria "upon review of a prescriber's written request"; some have criteria codes that allow online payment. PDF page 155: semaglutide (Ozempic 2mg/1.5mL, 2mg/3mL and 4mg/3mL prefilled pens and generic brands) and semaglutide tablets (Rybelsus), each with its published criteria and claim note.
- Nova Scotia: Pharmacare programs, exception status drugs (read November 14, 2026): Certain drugs are covered only when a person meets the criteria developed by the Atlantic or Canadian Expert Advisory Committees. Healthcare providers request coverage with the Standard Exception Status Drug Request Form or a specialized form, or online through Ocean.
- Sun Life: Prior Authorization Form, OZEMPIC (semaglutide) or generic products, 4233-PA-OZE-E-09-26 (read November 14, 2026)
- Sun Life: report for plan sponsors on drug management strategies (November 2025) (read November 14, 2026): Page 6 lists the five drugs of the category, Saxenda, Wegovy and Zepbound among them; page 9 has the optional category, its two strategies and Ozempic’s prior authorization.
- Canada Life: Workplace benefits, prior-authorization forms (read November 14, 2026): The list of forms: Ozempic and generics, Plosbrio, Poviztra, Rybelsus, Wegovy, Mounjaro and Zepbound; no Saxenda form.
- Canada Life: Drug Prior Authorization Form, semaglutide (Ozempic and generics), M6453(Ozempic)-10/26 (read November 14, 2026)
- Canada Life: Drug Prior Authorization Form, Wegovy (semaglutide), M6453(Wegovy)-8/26 (read November 14, 2026)
- Health Canada Drug Product Database: Ozempic, DIN 02471469 (semaglutide; Schedule: Prescription, Schedule D) (read November 11, 2026)
- Health Canada Drug Product Database: Wegovy, DIN 02528525 (semaglutide; Schedule: Prescription, Schedule D) (read November 11, 2026)
- Health Canada Drug Product Database: Mounjaro KwikPen, DIN 02551950 (tirzepatide; Schedule: Prescription) (read November 11, 2026)
- Health Canada Drug Product Database: Zepbound, DIN 02557509 (tirzepatide; Schedule: Prescription) (read November 11, 2026)
- Health Canada Drug Product Database: Apo-Semaglutide Injection, DIN 02568012 (semaglutide; Schedule: Prescription) (read November 11, 2026)
- Sun Life: optional drug category, prior authorization from October 15, 2024 (August 13, 2024) (read October 2, 2026): Read via the Wayback snapshot of 2026-06-09.
- Canada Life: Wegovy prior authorization form M6453 ("not covered under all benefit plans") (read October 2, 2026)
Health Canada compliance: GLP1Prices.ca displays drug names, prices, and quantities only. We do not make therapeutic claims. This website does not provide medical advice. Consult your healthcare provider about medication options.
Related
- RAMQ coverage in Quebec · What RAMQ's List of Medications says for the same drugs.
- Ontario Drug Benefit coverage · What the Ontario Drug Benefit program pays for the same drugs.
- Manitoba Pharmacare coverage · What Manitoba Pharmacare pays for the same drugs.
- Saskatchewan Drug Plan coverage · What the Saskatchewan Drug Plan pays for the same drugs.
- Alberta Blue Cross coverage · What Alberta's government drug plans pay for the same drugs.
- BC PharmaCare coverage · What BC PharmaCare pays for the same drugs.
- Coverage Checker · Check what your own plan covers.
Update log
- New page: what Nova Scotia Pharmacare pays for Ozempic, generic semaglutide, Mounjaro, Wegovy, Zepbound and Rybelsus, from the Nova Scotia Formulary of November 2026 and its exception status criteria, with cash prices and prescription options.